Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

lightmyfire2

Sep 24, 2021 09:35AM

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

golfyeti

Sep 24, 2021 10:03AM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

in response to

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

golfyeti

posted on Sep 24, 2021 10:19AM

yep Zenith down 31.82% to0.15 cents & rv down 6.35% to .59 pennies

tell me again why were suppose to be nice & sit quiet while this ceo crushes share value & wont even address his SH's after all his missed timelines etc etc etc ??

5 Recommendations

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study